Brind.

Goldman Sachs initiated coverage on Natera, which subsequently announced a collaboration with CytoDyn.

1 report, 1 independent Updated Jun 16

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Goldman Sachs Natera

Keep exploring

The entities involved

Goldman Sachs
American investment bank
- US-Iran truce aims to reopen Strait of Hormuz amid global monetary policy shifts and oil price drops.Mon 17:37
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
Natera
company in San Carlos, United States
- Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.Mon 02:47
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44

Coverage

Newest first; wire copies grouped

Jun 16yahoo.com